Research Topics
| Elizabeth A MorrisSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experienceE A Morris
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Radiology 214:67-72. 2000..To evaluate the ability to use breast magnetic resonance (MR) imaging to assess disease extent in patients with posterior breast masses who are suspected to have tumor invasion into underlying muscle...- Screening for breast cancer with MRIElizabeth A Morris
Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10021, USA
Semin Ultrasound CT MR 24:45-54. 2003.... - Breast cancer imaging with MRIElizabeth A Morris
Weill Medical College, Cornell University, New York, NY 10021, USA
Radiol Clin North Am 40:443-66. 2002..Further work is necessary to assess the utility of breast MRI in other settings, such as screening of women at high risk for breast cancer... - MRI of occult breast carcinoma in a high-risk populationElizabeth A Morris
Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 181:619-26. 2003..The purpose of this study was to determine the frequency of cancer and the positive predictive value of biopsy in the first screening round of breast MRI in women at high risk of developing breast cancer... - Breast MR imaging lexicon updatedElizabeth A Morris
Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10021, USA
Magn Reson Imaging Clin N Am 14:293-303, v. 2006..It is hoped that the radiologist uses the terms and concepts presented here as a template to which future lexicon terminology can be added... - Diagnostic breast MR imaging: current status and future directionsElizabeth A Morris
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Radiol Clin North Am 45:863-80, vii. 2007..Future applications are exciting and may possibly improve our ability to diagnose breast cancer, improving the patient's treatment options and ultimately patient outcome... - Histologic heterogeneity of masses at percutaneous breast biopsyElizabeth A Morris
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Breast J 8:187-91. 2002..Our data suggest that sampling part but not all of a mass may miss certain histologic components of the mass, but should not result in a failure to diagnose carcinoma... - To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy?Laura Liberman
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 179:679-83. 2002..This study was undertaken to determine whether complete percutaneous excision rather than sampling of the mammographic target conveys any significant advantage or disadvantage at stereotactic 11-gauge vacuum-assisted biopsy... - Ductal enhancement on MR imaging of the breastLaura Liberman
Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 181:519-25. 2003..The purpose of this study was to determine the prevalence and positive predictive value of ductal enhancement among MR imaging-detected breast lesions that had biopsy and to assess the histologic findings associated with ductal enhancement... - MR imaging findings in the contralateral breast of women with recently diagnosed breast cancerLaura Liberman
Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
AJR Am J Roentgenol 180:333-41. 2003..Cancer was found in 20% of women who underwent contralateral breast biopsy and in 5% of women who underwent contralateral breast MR imaging... - Breast lesions detected on MR imaging: features and positive predictive valueLaura Liberman
Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 179:171-8. 2002..Final assessment categories were significant predictors of carcinoma... 
Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS studySunitha B Thakur
Departments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Magn Reson Imaging 33:855-63. 2011..Reference standard was histology...- Screening breast MR imaging in women with a history of lobular carcinoma in situJanice S Sung
Department of Radiology, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065, USA
Radiology 261:414-20. 2011..To assess the utility of screening magnetic resonance (MR) imaging in the detection of otherwise occult breast cancers in women with a history of lobular carcinoma in situ (LCIS)... - Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imagingValencia King
Department of Radiology, Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Radiology 264:670-8. 2012.... - Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?Sarah A McLaughlin
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 112:1214-21. 2008..In the current study, recent experience with PM was described and the value of preoperative magnetic resonance imaging (MRI) was analyzed in selecting patients for PM with or without SLNB... - MR imaging of the ipsilateral breast in women with percutaneously proven breast cancerLaura Liberman
Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 180:901-10. 2003..The yield was highest in women with a family history of breast cancer or infiltrating lobular histology in the index cancer. Change after biopsy was infrequent and did not interfere with the MR imaging interpretation... - Preoperative MR imaging-guided needle localization of breast lesionsElizabeth A Morris
Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 178:1211-20. 2002..The positive predictive value of MR imaging-guided needle localization (30.7%) was comparable to that reported for mammographically guided needle localization and was highest in women with synchronous breast cancer... - Breast MRI after conservation therapy: usual findings in routine follow-up examinationsJie Li
Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065, USA
AJR Am J Roentgenol 195:799-807. 2010..The objective of our study was to define the usual alterations in the ipsilateral and contralateral breast on MRI of women who have undergone surgery and radiation for the treatment of primary breast cancer... - Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imagingJennifer H Menell
Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Breast J 11:382-90. 2005..In this study, MRI was significantly more sensitive than mammography in DCIS detection. In women with known or suspected DCIS, MRI may have an important role to play in assessing the extent of disease in the breast... - Fast MRI-guided vacuum-assisted breast biopsy: initial experienceLaura Liberman
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 181:1283-93. 2003..MRI-guided biopsy was performed with a vacuum-assisted probe, followed by placement of a localizing clip, and then needle localization for surgical excision. Vacuum-assisted biopsy and surgical histology were correlated... - Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopyLia Bartella
Department of Radiology, Breast Imaging Section H 118, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 245:80-7. 2007.... - Imaging histologic discordance at MRI-guided 9-gauge vacuum-assisted breast biopsyJung Min Lee
Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 189:852-9. 2007..The purpose of this study was to determine the frequency of discordance at MRI-guided vacuum-assisted biopsy and to assess the cancer rate in discordant lesions... - Breast lesions detected with MR imaging: utility and histopathologic importance of identification with USLinda R LaTrenta
Department of Radiology, Memorial Sloan Kettering Guttman Diagnostic Center, 55 Fifth Ave, 12th Floor, New York, NY 10003, USA
Radiology 227:856-61. 2003..To determine the utility and histopathologic importance of ultrasonographic (US) depiction of breast lesions detected with magnetic resonance (MR) imaging... 
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIALNola M Hylton
Department of Radiology, University of California, San Francisco, 1600 Divisadero St, C250, Box 1667, San Francisco, CA 94115, USA
Radiology 263:663-72. 2012..To compare magnetic resonance (MR) imaging findings and clinical assessment for prediction of pathologic response to neoadjuvant chemotherapy (NACT) in patients with stage II or III breast cancer...- The predictive value of ductography and magnetic resonance imaging in the management of nipple dischargeMary Morrogh
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:3369-77. 2007..The aim of this study was to determine the predictive value of ductography (DG) and magnetic resonance imaging (MRI) in this setting... - Screening breast MR imaging in women with a history of chest irradiationJanice S Sung
Department of Radiology, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065, USA
Radiology 259:65-71. 2011..To assess the utility of screening magnetic resonance (MR) imaging in detecting otherwise occult breast cancers in women with a history of radiation therapy to the chest... - MRI identifies otherwise occult disease in select patients with Paget disease of the nippleMary Morrogh
Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 206:316-21. 2008..The purpose of this study was to evaluate the role of breast MRI in this setting... - Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-upNiamh M Hambly
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, New York, NY, USA
AJR Am J Roentgenol 196:218-24. 2011..The aim of this study was to determine the effect of background parenchymal enhancement on short-interval follow-up, biopsy, and cancer detection rate on baseline screening MRI in a high-risk group... - Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion sizeLaura Liberman
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 186:426-30. 2006..The purpose of this study was to determine the impact of lesion size on the positive predictive value (PPV) of biopsy in MRI-detected breast lesions... - Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imagingValencia King
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Breast J 18:527-34. 2012..A significant association exists between treatment with tamoxifen and decreases in BPE, cysts, and FGT on breast MRI... - Patient follow-up after concordant histologically benign imaging-guided biopsy of MRI-detected lesionsJanice S Sung
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
AJR Am J Roentgenol 198:1464-9. 2012..A 6-month follow-up MRI is suggested as the most appropriate interval to identify lesions that were missed at biopsy without clinically significant delay in diagnosis of those lesions that are malignant... - Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommendedMatthias Meissnitzer
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
AJR Am J Roentgenol 193:1025-9. 2009.... - Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsyLaura Liberman
Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 188:684-90. 2007.... - Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary studyLia Bartella
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 239:686-92. 2006..To prospectively evaluate the diagnostic performance of magnetic resonance (MR) spectroscopy in patients with suspicious lesions or biopsy-proved cancers at MR imaging by using histologic findings as the reference standard... - Nonpalpable mammographically occult invasive breast cancers detected by MRILia Bartella
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, H118, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 186:865-70. 2006..The purpose of this study was to determine the MRI findings and histology of clinically and mammographically occult invasive breast cancers detected by MRI... - Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk womenLaura Liberman
Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 98:377-88. 2003..The purpose of the current study was to determine the frequency of 'probably benign' interpretations at breast magnetic resonance (MR) imaging screening of high-risk women and the frequency of subsequent malignancy in these women... - Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinomaMaxine S Jochelson
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Radiology 266:743-51. 2013.... - Background parenchymal enhancement at breast MR imaging and breast cancer riskValencia King
Department of Radiology, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, 300 E 66th St, Room 715, New York, NY 10065, USA
Radiology 260:50-60. 2011..To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging... - Utility of breast magnetic resonance imaging in patients with occult primary breast cancerClaire L Buchanan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 12:1045-53. 2005..CONCLUSIONS: Breast MRI detects mammographically occult cancer in half of women with axillary metastases, regardless of breast density. MRI is a powerful tool for stage II and stage IV patients with occult primary breast cancer... - Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-upSandra B Brennan
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, New York, NY 10065, USA
Radiology 261:92-9. 2011..To determine the rate of canceled magnetic resonance (MR) imaging-guided breast biopsies due to nonvisualization of the lesion and to assess associated features and outcome data for these cases... - Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy?Laura Liberman
Breast Imaging Research Programs, Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 186:1328-34. 2006..The study objective was to determine the cancer frequency in lesions yielding a benign, concordant diagnosis of papilloma at percutaneous breast biopsy... - One operation after percutaneous diagnosis of nonpalpable breast cancer: frequency and associated factorsLaura Liberman
Department of Radiology, Breast Imaging Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 178:673-9. 2002..5% of women who had mastectomy. Among women who had breast conservation, one operation was significantly more likely if histologic underestimation was absent or if a mammographic mass was present... - Bracketing wires for preoperative breast needle localizationL Liberman
Department of Radiology, Breast Imaging Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 177:565-72. 2001..Bracketing wires may assist the surgeon in achieving complete excision of calcifications, but bracketing wires do not ensure clear histologic margins of resection... - Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRIValencia King
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA
Eur Radiol 22:2641-7. 2012..To evaluate the effect of menopausal status on the background parenchymal enhancement (BPE) and amount of fibroglandular tissue (FGT) on breast MRI... - MRI follow-up after concordant, histologically benign diagnosis of breast lesions sampled by MRI-guided biopsyJie Li
Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1114 First Ave, Second Floor, New York, NY 10065, USA
AJR Am J Roentgenol 193:850-5. 2009..This retrospective study was undertaken to evaluate appropriate timing and imaging interpretation for the initial follow-up MRI when a benign, concordant histology is obtained using MRI-guided breast biopsy... - Imaging-histologic discordance at percutaneous breast biopsyL Liberman
Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 89:2538-46. 2000..The purpose of the current study was to determine the frequency of imaging-histologic discordance at percutaneous breast biopsy and to assess the likelihood of carcinoma in these discordant lesions... - The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivoWei Huang
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Proc Natl Acad Sci U S A 105:17943-8. 2008..Thus, incorporation of the SSM into the screening protocols would have precluded all 68% of the biopsy/pathology procedures that yielded benign findings. The SM/SSM difference is well understood from molecular first principles... - Advances in breast imaging: magnetic resonance imagingLia Bartella
Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Avenue, New York 10021 NY, USA
Curr Oncol Rep 8:7-13. 2006..Magnetic resonance spectroscopy is a promising technique that may decrease the number of benign biopsies generated by breast MRI in the clinical setting... - Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal massesS J Kim
Department of Radiology, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 177:551-7. 2001..CONCLUSION: This study suggests that the mammographic BI-RADS lexicon with some modifications may be applied to describe the features of infiltrating carcinoma seen on breast MR imaging... - Calcifications highly suggestive of malignancy: comparison of breast biopsy methodsL Liberman
Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 177:165-72. 2001..Stereotactic 11-gauge vacuum-assisted biopsy, as compared with 14-gauge automated core or 14-gauge vacuum-assisted biopsy, is significantly more likely to spare a surgical procedure and has the highest cost savings... - Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancerM L Quan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 10:1048-53. 2003..CONCLUSIONS: MRI of the breast identifies unsuspected multicentric or contralateral cancer in patients with ILC. These findings support the use of MRI in selected patients with ILC, particularly in the ipsilateral breast... - Cancer staging with breast MR imagingE A Morris
Department of Radiology, Memorial Sloan-Kettering Cancer Center, College of Cornell University, New York, New York 10021, USA
Magn Reson Imaging Clin N Am 9:333-44, vi-vii. 2001..There are many important questions regarding the role of MR imaging in breast cancer staging that must be addressed by future research and involvement of MR imaging of the breast in clinical trials... - Learning curve for stereotactic breast biopsy: how many cases are enough?L Liberman
Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
AJR Am J Roentgenol 176:721-7. 2001..The objective of this study was to evaluate the learning curve for stereotactic breast biopsy... - An apparatus for MR-guided breast lesion localization and core biopsy: design and preliminary resultsE Schneider
GE Corporate Research and Development, Magnetic Resonance Program, Niskayuna, New York, USA
J Magn Reson Imaging 14:243-53. 2001..43 mm. However, this contribution was, on average, 42% of the mean measured 2.35 +/- 1.65 mm offset. The new device design provided an accurate and simple guidance method for localization or core biopsy of MR-visible breast lesions... - Illustrated breast MR lexiconE A Morris
Department of Radiology, Weill Medical College of Cornell University and Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Semin Roentgenol 36:238-49. 2001..It is hoped that radiologists will use the terms and concepts presented here as a template to which future lexicon terminology can be added...